commercialization agreement
Boditech Med, SphingoTec Ink Commercialization Deal for Kidney Injury Test
The firms will market a point-of-care test that incorporates SphingoTec's kidney function biomarker and is designed for use on Boditech Med's AFIAS instruments.
Mainz Biomed, Fugene Genetics Partner on Colorectal Cancer Test Launch in Israel
The deal is one of several struck this year by Mainz Biomed for the marketing of its stool sample-based ColoAlert molecular test for colorectal cancer.
Mainz Biomed Inks Commercialization Deals for Colorectal Cancer Test in UK, Spain
The test combines analysis of DNA, mRNA, and fecal immunohistochemistry to identify cancer in asymptomatic individuals from a stool sample.
Beckman Coulter Partners with MeMed to Develop, Commercialize Host Immune Response Test
MeMed's BV test distinguishes between bacterial and viral infections by measuring three host-immune proteins.
Unilabs, Ambry Genetics Partner to Market Research-Use Genomic Testing Services Internationally
The companies aim to offer genetic testing for biopharma and government-sponsored research in Europe, Latin America, and the Middle East.